Evidence map›Paper›PMID 27921279›Full record

ArticleBiomedical microdevices2016

Biocompatibility of fluids for multiphase drops-in-drops microfluidics.

Aishah Prastowo, Alexander Feuerborn, Peter R Cook, Edmond J Walsh

Open access · hybridAbstract read
In one paragraph

Article in Biomedical microdevices, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Aishah PrastowoOsney Thermo-Fluids Laboratory, Department of Engineering Science, University of Oxford, Osney Mead, Oxford, OX2 0ES, UK.
Alexander FeuerbornSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK.
Peter R CookSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK.
Edmond J WalshOsney Thermo-Fluids Laboratory, Department of Engineering Science, University of Oxford, Osney Mead, Oxford, OX2 0ES, UK. edmond.walsh@eng.ox.ac.uk.
University of Oxford · GB

Funding

Medical Research Council MC_PC_15029Medical Research Council MR/K010867/1
6 · The paper itself

Abstract

This paper addresses the biocompatibility of fluids and surfactants in the context of microfluidics and more specifically in a drops-in-drops system for mammalian cell based drug screening. In the drops-in-drops approach, three immiscible fluids are used to manipulate the flow of aqueous microliter-sized drops; it enables merging of drops containing cells with drops containing drugs within a Teflon tube. Preliminary tests showed that a commonly-used fluid and surfactant combination resulted in significant variability in gene expression levels in Jurkat cells after exposure to a drug for four hours. This result led to further investigations of potential fluid and surfactant combinations that can be used in microfluidic systems for medium to long-term drug screening. Results herein identify a fluid combination, HFE-7500 and 5-cSt silicone oil + 0.25% Abil EM180, which enabled the drops-in-drops approach; this combination also allowed gene expression at normal levels comparable with the conventional drug screening in both magnitude and variability.

Indexed as

Lab-On-A-Chip DevicesAnimalsCell SurvivalDrug Evaluation, PreclinicalHumansJurkat CellsMaterials TestingMiceSurface-Active AgentsSurface-Active AgentsBiocompatibilityDrops-in-dropsDrug screeningMammalian cellSurfactantToxicity

Identifiers

PMID27921279
PMCPMC5138278
OpenAlexW2559905144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.